R

Arcus Biosciences
D

RCUS

23.710
USD
0.70
(3.04%)
مغلق
حجم التداول
35,413
الربح لكل سهم
-4
العائد الربحي
-
P/E
-7
حجم السوق
2,972,036,076
أصول ذات صلة المقالات
المزيد

العنوان: Arcus Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.